Neoadjuvant epirubicin, gemcitabine and docetaxel for primary breast cancer: Long‐term survival data and major prognostic factors based on two consecutive neoadjuvant phase I/II trials
| Image |  |
|---|---|
| Description | scientific article published on March 16, 2013 |
| Author/s | |
| Publication date | March 16, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.28094 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |